Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
107.00
-3.60 (-3.25%)
At close: Apr 1, 2025, 4:00 PM
106.19
-0.81 (-0.75%)
After-hours: Apr 1, 2025, 7:59 PM EDT

Neurocrine Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
10,66813,82012,94611,4828,0808,955
Upgrade
Market Cap Growth
6.75%6.75%12.75%42.11%-9.78%-9.54%
Upgrade
Enterprise Value
10,08812,87812,12410,9667,7668,528
Upgrade
Last Close Price
107.00136.50131.76119.4485.1795.85
Upgrade
PE Ratio
32.5240.4951.8574.3290.1821.99
Upgrade
Forward PE
17.2218.1521.3422.5324.5522.30
Upgrade
PS Ratio
4.565.876.867.717.138.56
Upgrade
PB Ratio
4.115.345.806.725.887.95
Upgrade
P/TBV Ratio
5.435.435.916.905.887.95
Upgrade
P/FCF Ratio
19.1524.8035.8035.5634.6641.15
Upgrade
P/OCF Ratio
17.9223.2133.2033.8331.5039.19
Upgrade
PEG Ratio
0.490.310.650.660.370.37
Upgrade
EV/Sales Ratio
4.285.476.437.376.858.15
Upgrade
EV/EBITDA Ratio
16.5321.1129.1441.4435.5125.37
Upgrade
EV/EBIT Ratio
17.3022.0930.7144.0437.3826.04
Upgrade
EV/FCF Ratio
18.1023.1133.5333.9633.3239.19
Upgrade
Debt / Equity Ratio
0.190.190.190.150.320.37
Upgrade
Debt / EBITDA Ratio
0.760.760.990.941.881.19
Upgrade
Debt / FCF Ratio
0.890.891.190.811.891.90
Upgrade
Asset Turnover
0.680.680.670.670.600.69
Upgrade
Inventory Turnover
15.9915.9916.4814.8511.7112.59
Upgrade
Quick Ratio
3.063.062.252.493.655.14
Upgrade
Current Ratio
3.403.402.452.703.965.45
Upgrade
Return on Equity (ROE)
14.16%14.16%12.68%10.03%7.17%46.20%
Upgrade
Return on Assets (ROA)
10.46%10.46%8.78%7.01%6.82%13.46%
Upgrade
Return on Capital (ROIC)
12.68%12.68%10.66%8.22%7.75%15.33%
Upgrade
Return on Capital Employed (ROCE)
18.20%18.20%15.20%13.60%11.40%21.20%
Upgrade
Earnings Yield
3.20%2.47%1.93%1.35%1.11%4.55%
Upgrade
FCF Yield
5.22%4.03%2.79%2.81%2.89%2.43%
Upgrade
Buyback Yield / Dilution
-2.67%-2.67%-2.12%-1.02%-0.10%-2.19%
Upgrade
Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q